Heterogeneous Cu(II)/L-His@Fe3O4 nanocatalyst: a novel, efficient and magnetically-recoverable catalyst for organic transformations in green solvents

Masoomeh Norouzi, Arash Ghorbani-Choghamarani* and Mohsen Nikoorazm
Department of Chemistry, Faculty of Science, Ilam University, P.O. Box 69315516, Ilam, Iran. E-mail: arashghch58@yahoo.com; a.ghorbani@mail.ilam.ac.ir; Fax: +98 841 2227022; Tel: +98 841 2227022

Received 4th August 2016 , Accepted 19th September 2016

First published on 20th September 2016


Abstract

A novel, efficient and green Cu(II)/L-His@Fe3O4 catalyst has been applied successfully in the synthesis of heterocyclic compounds. The resulting catalyst was used in the synthesis of 2,3-dihydroquinazolin-4(1H)-ones, polyhydroquinolines and 2-amino-6-(arylthio)pyridine-3,5-dicarbonitriles as biologically interesting compounds. The present research is focused on investigation of recycling, reusability and stability of the catalyst in phase reactions. The Cu(II)/L-His@Fe3O4 catalyst was used at least six times with comparable activities to that of fresh catalyst. The chemical composition and the structure of the catalyst were analysed by TGA/DTG, EDS, XRD, VSM, FT-IR and SEM.


Introduction

Metal–organic interfaces with biologically active molecules are important issues in biocatalysis, biocompatibility, and biosensors. Histidine and its peptides are interesting for their possible applications, and one example is the electrochemical detection of metal ions.1

It is well-known that histidine (2-amino-3-(4-imidazolyl)propanoic acid, His) is an essential amino acid for human growth and repair of tissues and acts as a neurotransmitter in the central nervous system of mammals.2,3 The imidazole side chain of histidine can serve as a coordinating ligand in metal ion transmission in biological bases4 and was detected in the active sites of certain enzymes (Scheme 1).5


image file: c6ra19776k-s1.tif
Scheme 1 A potential tridentate ligand, L-histidine.

Copper is an essential metal element for all living organisms.6,7

Since the discovery of copper(II)–L-histidine species in human blood (Sarkar et al., 1966), extensive research has been carried out to determine its role in copper uptake into cells.8–11

The solid state monocrystal X-ray structural analysis of this complex shows four coordinate square-planar arrangement around copper ion with nitrogen and oxygen atoms in trans coordination (Scheme 2).12


image file: c6ra19776k-s2.tif
Scheme 2 The structure of the Cu(L-His)2 complex.

Immobilization of copper(II)–L-histidine onto solid surface is the key step for creating a recoverable and reusable catalyst or reagent. In this context, magnetic nanoparticles (MNPs) materials have been efficiently used as environmentally friendly solid supports for immobilizing homogeneous catalysts.

The main advantage of this catalytic system is high surface area and low toxicity, potential towards applications in various fields such as uses in disciplines including physics, biomedicine, biotechnology, material science and catalyst support. In addition the magnetic nanoparticles can be efficiently isolated from the reaction medium by magnetic separation.13–15

2,3-Dihydroquinazolin-4(1H)-ones and polyhydroquinolines are an important group of nitrogen containing heterocyclic that have attracted much attention because of their diverse therapeutic and pharmacological properties, such as vasodilator, hepatoprotective, antiatherosclerotic, antidefibrillatory, antipyretic, analgesic.16–23

The pyridine ring systems represent the major class of heterocycles and their analogues show diverse biological and physiological activities.24 Among the pyridine derivatives, 2-amino-6-(arylthio)pyridine-3,5-dicarbonitrile is a privileged scaffold for developing pharmaceutical agents because various compounds with this structural motif display significant and diverse biological activities. Compounds with 2-amino-3,5-dicarbonitrile-6-thio-pyridines ring system exhibit diverse pharmacological activities and are useful as anti-prion, anti-hepatitis B virus, anti-bacterial, and anticancer agents and as potassium channel openers for treatment of urinary incontinence.25–29

In this communication, we report preparation and characterization of a novel, efficient and green Cu(II)/L-His@Fe3O4 catalyst for the synthesis of 2,3-dihydroquinazolin-4(1H)-ones, polyhydroquinolines and 2-amino-6-(arylthio)pyridine-3,5-dicarbonitrile through MCRs. Furthermore, the catalyst can be easily separated with an external magnet without using extra organic solvents or more filtration steps. Thus, the technology is green and solves the problems associated with mass transfer and recycling in multi-component reactions.

Results and discussion

The process of Cu(II)/L-His@Fe3O4 synthesis is schematically described in Scheme 3.
image file: c6ra19776k-s3.tif
Scheme 3 Synthesis of Cu(II)/L-His@Fe3O4.

Characterization of the Cu(II)/L-His@Fe3O4

The catalyst has been characterised using a number of different complementary techniques.

FTIR spectra of Fe3O4 nanoparticles (a), functionalized Fe3O4 (b–e) and recovered catalyst (f) are shown in Fig. 1. Typical peaks at 573 cm−1 and 3500–2800 cm−1 originated from stretching vibration of the Fe–O and O–H (Fe3O4 nanoparticles Fig. 1a). The C–H and N–H vibration bands in the 2922–2852 cm−1 and 1650–1500 cm−1 region were found in the FTIR spectra of Fig. 1b, indicating the successful attachment of APTES on the surface of Fe3O4 nanoparticles matrix. The bands observed at 1710 cm−1 and 1642 cm−1 in Fig. 1c could be attributed to the stretching frequency of C[double bond, length as m-dash]O and C[double bond, length as m-dash]C respectively (amide 1 band).


image file: c6ra19776k-f1.tif
Fig. 1 FT-IR spectra of (a) Fe3O4 nanoparticles, (b) amino-functionalized, (c) MNP-acryloxyl, (d) L-His@Fe3O4, (e) Cu(II)/L-His@Fe3O4 and (f) recovered catalyst.

The L-histidine–Fe3O4 absorption bands at 3411 cm−1 corresponding to the stretching vibration of O–H were recorded together with the N–H absorption bands. The absorption bands in the range of 3030–3130 cm−1 are due to asymmetric valence vibrations of the ammonium (NH3+) group. The symmetric absorption vibrations in 2080–2140 cm−1 or 2530–2760 cm−1, depend on amino acid chemical structures. The peak of bending absorption of carboxylate (COO) group appears at 1610–1641 cm−1. The bands appeared at 1144 and 1622 cm−1 can be assigned to the vibration of C–N and C[double bond, length as m-dash]N in imidazolium rings, respectively.

The infrared spectrum of the Cu(II)/L-His@Fe3O4 complex has shown changes in the position and profiles of some bands as compared to those of the free L-histidine@Fe3O4, suggesting participation of the groups that produce these bands in the coordination with copper atoms. Major changes are related to the carboxylate and amine bands. The infrared spectrum of the Cu(II)/L-His@Fe3O4 complex exhibits (Cu–O) and (Cu–N) stretching bands at 973 cm−1 and 448 cm−1, respectively. These results confirm the introduction of carboxylate and amino nitrogen groups of L-histidine to Cu(II) ions through coordination mode.

The infrared spectrum of recovered catalyst (Fig. 1f) indicates that the catalyst can be recycled six times without any significant change in its structure.

TGA/DTA analysis of the samples is presented in Fig. 2. We assign the first weight loss to water leaving the sample. The latter losses are assigned to decomposition of iron oxide phase transitions to thermodynamically more stable Fe2O3 phase (the DTA patterns are the signature of the recrystallization and phase transformation from Fe3O4 to γ-Fe2O3).


image file: c6ra19776k-f2.tif
Fig. 2 TGA/DTA curves of Fe3O4 and Cu(II)/L-His@Fe3O4.

The TGA curve of Cu(II)/L-His@Fe3O4 showed the first weight loss below 100 °C due to desorption of physisorbed water. This was followed by a gradual decrease in the weight after 250 °C. The metal–organic structure grafting to the Fe3O4 surface were decomposed in the temperature range of 250 to 450 °C. The exothermic peak at about 402 °C indicated the beginning of decomposition of the organic surfactant, the amount of loading organic groups is estimated to be 26.87% (w/w).

Fig. 3 shows the magnetic curve for Fe3O4 nanoparticles and Cu(II)/L-His@Fe3O4 catalyst. Ms value for Cu(II)/L-His@Fe3O4 nanoparticle was found to be 34.7 emu g−1, which is lower than the saturation magnetization of the Fe3O4 bulk materials (77 emu g−1). This decrease in Ms could mainly be attributed to the small particle surface effect that becomes more prominent as the particle size decreases.


image file: c6ra19776k-f3.tif
Fig. 3 Magnetization curves for Fe3O4 and Cu(II)/L-His@Fe3O4.

SEM images of Cu(II)/L-His@Fe3O4 at different magnification (a and b) and EDS pattern of Cu(II)/L-His@Fe3O4 (c) are shown in Fig. 4.


image file: c6ra19776k-f4.tif
Fig. 4 SEM images of Cu(II)/L-His@Fe3O4 at different magnification (a and b). EDS pattern of Cu(II)/L-His@Fe3O4 (c).

The scanning electron microscopy (SEM) of Cu(II)/L-His@Fe3O4 materials shows that they consist of spherical particles and have a relatively uniform diameter of 8–15 nm (Fig. 4a and b). The shape of the support is retained after immobilization of the metal complexes. The electron dispersive spectroscopy (EDS) spectra of the Cu(II)/L-His@Fe3O4 was taken at random points on the surface.

The EDS results of the core–shell structure confirms the presence of Si, C, O, N, Fe, and Cu elements, indicating the successful attachment of the copper(II)–L-histidine on the surface Fe3O4 MNPs (Fig. 4c).

Powder XRD diffraction patterns (Fig. 5) obtained for the copper(II)–L-histidine exhibited very broad peaks indicating the ultrafine nature and small crystallite size of the particles. The diffraction peaks located at 20.94°, 35.25°, 41.48°, 50.72°, 63.02°, 67.50°, and 74.72° have been keenly indexed as a cubic spinel structure. The average particle size of the sample was found to be 14.28 nm which is derived from the FWHM of more intense peak corresponding to 311 planes located at 41.48° using Scherrer's formula.


image file: c6ra19776k-f5.tif
Fig. 5 XRD patterns of Cu(II)/L-His@Fe3O4.

The Cu loading of the prepared catalyst, measured by coupled plasma (ICP-AES) analysis, showed a value of about 0.96 mmol g−1 of catalyst.

ICP-AES analysis of catalysts recycled showed minor changes of Cu contents (0.92 mmol g−1). These phenomena indicate that the multi component reactions indeed go through a heterogeneous catalytic reaction process. In addition, the very low metal leached during the reaction.

The transmission electron microscopy (TEM) image of Cu(II)/L-His@Fe3O4 and recovered catalyst are illustrated in Fig. 6a and b. Particles are observed to have spherical morphology from Fig. 6a and b. Average particle size is estimated at 5–15 nm which show a close agreement with the values calculated by XRD analysis. TEM image of recycled catalyst was showed that the morphology of Cu(II)/L-His@Fe3O4 remained after recovery (Fig. 6b).


image file: c6ra19776k-f6.tif
Fig. 6 TEM images of (a) Cu(II)/L-His@Fe3O4 and (b) recovered catalyst.

Catalytic studies

In continuation of our interest on environmentally benign chemical processes for synthesis of biologically molecules,30–35 we developed a new method for preparation of a stable, cheap and efficient heterogeneous Cu(II)/L-His@Fe3O4 nanocatalyst which has been used with excellent activity in multi component reactions (Schemes 4 and 5).
image file: c6ra19776k-s4.tif
Scheme 4 Synthesis of 2,3-dihydroquinazolin-4(1H)-ones.

image file: c6ra19776k-s5.tif
Scheme 5 Synthesis of polyhydroquinolines.

In the first part of our program, the catalytic activity of Cu(II)/L-His@Fe3O4 was evaluated in the synthesis of 2,3-dihydroquinazolin-4(1H)-ones (DHQ) derivatives. In order to optimize the reaction conditions, the reaction of 4-chlorobenzaldehyde with 2-aminobenzamide was chosen as a model reaction. As shown in Table 1, different amounts of catalyst between 2–6 mg were used for this reaction, and 4 mg of Cu(II)/L-His@Fe3O4 nanocatalyst was found to be optimal. For higher amounts of the catalyst, the desired product was obtained in a nearly quantitative yield (Table 1, entries 5).

Table 1 Optimization of the amount of the Cu(II)/L-His@Fe3O4
Entry Catalyst (mg) Yield of DHQa (%) Yield of PHQb (%)
a Reaction conditions for the synthesis DHQ: 4-chlorobenzaldehyde (1 mmol), 2 aminobenzamide (1 mmol) and ethanol solvent (10 mL) at reflux temperature.b Reaction conditions for the synthesis PHQ: 4-chlorobenzaldehyde (1 mmol), dimedone (1 mmol), ethyl acetoacetate (1 mmol), ammonium acetate (1.2 mmol).
1 Trace 32
2 2 55 62
3 3 70 80
4 4 99 98
5 6 99 98


In the second part of our investigation, we demonstrated that Cu(II)/L-His@Fe3O4 can also be used in the synthesis of polyhydroquinolines (PHQ) derivatives (Scheme 5).

During our initial studies, 4-chlorobenzaldehyde was selected as substrates for the model reaction. Various conditions were screened and the results are summarized in Table 1.

The reactions was carried out in the absence and presence of Cu(II)/L-His@Fe3O4 catalyst. It was found that in the absence of the catalyst the reaction was slightly sluggish and only trace amount of product was obtained after 24 h. But when the reaction was conducted in the presence of Cu(II)/L-His@Fe3O4 (4 mg), the reaction was completed yielding (98%) in 120 min (entry 4).

Finally, the outset, the model reaction was carried out in the presence of 4 mg catalyst in ethanol at 50 °C temperature.

Under the optimized reaction conditions, the generality of substrates was checked next. Different aldehydes were used for the synthesis of 2,3-dihydroquinazolin-4(1H)-ones (Table 2) and polyhydroquinolines derivatives (Table 3). As shown in Tables 2 and 3 most of the aromatic and aliphatic aldehydes would give the products in good yields. A variety of functional groups of aldehydes are known to tolerate this reaction condition, which include alkoxyl, methyl, nitro, Cl, F, and OH groups. However, the substituents on the phenyl ring of aromatic aldehydes had same influence on the yields.

Table 2 Synthesis of 2,3-dihydroquinazolin-4(1H)-one derivativesa
Entry Aldehyde Product Time (min) Yieldb (%) Mp (°C) (ref.)
a Reaction conditions: aldehyde (1 mmol), 2-aminobenzamide (1 mmol), catalyst (4 mg) and ethanol solvent (5 mL) at reflux temperature.b Isolated yields.
1 image file: c6ra19776k-u1.tif image file: c6ra19776k-u2.tif 25 99 202–203 (ref. 30)
2 image file: c6ra19776k-u3.tif image file: c6ra19776k-u4.tif 10 98 225–226 (ref. 30)
3 image file: c6ra19776k-u5.tif image file: c6ra19776k-u6.tif 40 97 197–200 (ref. 30)
4 image file: c6ra19776k-u7.tif image file: c6ra19776k-u8.tif 10 98 182–183 (ref. 30)
5 image file: c6ra19776k-u9.tif image file: c6ra19776k-u10.tif 23 94 211–212 (ref. 30)
6 image file: c6ra19776k-u11.tif image file: c6ra19776k-u12.tif 15 96 223–224 (ref. 30)
7 image file: c6ra19776k-u13.tif image file: c6ra19776k-u14.tif 35 98 167–168 (ref. 30)
8 image file: c6ra19776k-u15.tif image file: c6ra19776k-u16.tif 25 98 192–193 (ref. 30)
9 image file: c6ra19776k-u17.tif image file: c6ra19776k-u18.tif 32 96 184–185 (ref. 30)
10 image file: c6ra19776k-u19.tif image file: c6ra19776k-u20.tif 60 94 244–245 (ref. 30)
11 image file: c6ra19776k-u21.tif image file: c6ra19776k-u22.tif 80 86 272–273 (ref. 30)
12 image file: c6ra19776k-u23.tif image file: c6ra19776k-u24.tif 23 98 280–282 (ref. 21)
13 image file: c6ra19776k-u25.tif image file: c6ra19776k-u26.tif 15 98 220–222 (ref. 21)
14 image file: c6ra19776k-u27.tif image file: c6ra19776k-u28.tif 50 96 191–192 (ref. 21)
15 image file: c6ra19776k-u29.tif image file: c6ra19776k-u30.tif 100 84 202–204 (ref. 21)
16 image file: c6ra19776k-u31.tif image file: c6ra19776k-u32.tif 17 98 157–159 (ref. 30)
17 image file: c6ra19776k-u33.tif image file: c6ra19776k-u34.tif 45 96 160–164 (ref. 31)


Table 3 Synthesis of polyhydroquinolines derivativesa
Entry Aldehyde Product Time (min) Yieldb (%) Mp (°C) (ref.)
a Reaction conditions: arylaldehyde (1 mmol), dimedone (1 mmol), ethyl acetoacetate (1 mmol), NH4OAc (1.2 mmol), catalyst (4 mg) and ethanol solvent (5 mL) at 50 °C.b Isolated yields.
1 image file: c6ra19776k-u35.tif image file: c6ra19776k-u36.tif 90 98 239–241 (ref. 17)
2 image file: c6ra19776k-u37.tif image file: c6ra19776k-u38.tif 120 96 252–254 (ref. 17)
3 image file: c6ra19776k-u39.tif image file: c6ra19776k-u40.tif 110 96 249–252 (ref. 32)
4 image file: c6ra19776k-u41.tif image file: c6ra19776k-u42.tif 100 94 247–249 (ref. 17)
5 image file: c6ra19776k-u43.tif image file: c6ra19776k-u44.tif 90 95 201–202 (ref. 17)
6 image file: c6ra19776k-u45.tif image file: c6ra19776k-u46.tif 95 92 207–209 (ref. 17)
7 image file: c6ra19776k-u47.tif image file: c6ra19776k-u48.tif 110 98 176–178 (ref. 32)
8 image file: c6ra19776k-u49.tif image file: c6ra19776k-u50.tif 100 90 183–185 (ref. 17)
9 image file: c6ra19776k-u51.tif image file: c6ra19776k-u52.tif 90 96 234–236 (ref. 19)
11 image file: c6ra19776k-u53.tif image file: c6ra19776k-u54.tif 90 96 230–232 (ref. 17)
11 image file: c6ra19776k-u55.tif image file: c6ra19776k-u56.tif 100 93 217–219 (ref. 17)
12 image file: c6ra19776k-u57.tif image file: c6ra19776k-u58.tif 150 92 162–164 (ref. 17)
13 image file: c6ra19776k-u59.tif image file: c6ra19776k-u60.tif 120 92 170–172 (ref. 17)
14 image file: c6ra19776k-u61.tif image file: c6ra19776k-u62.tif 90 91 146–147 (ref. 17)


During the course of one of our drug discovery programs, we became interested in the synthesis of 2-amino-6-(arylthio)pyridine-3,5-dicarbonitrile (Scheme 6). These pyridine derivatives are a privileged scaffold for developing pharmaceutical agents because various compounds with this structural motif display significant and diverse biological activities.


image file: c6ra19776k-s6.tif
Scheme 6 Synthesis of 2-amino-6-(arylthio)pyridine-3,5-dicarbonitrile.

We initiated our study with the reaction between 4-methoxybenzaldehyde, 4-bromobenzenethiol and malononitrile as a model reaction (Table 4).

Table 4 Optimization of reaction conditions for the one-pot synthesis of pyridines
Entry Solvent Catalyst (mg) Time (min) Yielda (%)
a Reaction conditions: 4-methoxybenzaldehyde (1 mmol), 4-bromobenzenethiol (1 mmol), malononitrile (2 mmol) in water (5 mL) at 80 °C for 60 min.
1 H2O No catalyst 24 h Trace
2 H2O 2 60 23
3 H2O 3 60 61
4 H2O 5 60 91
5 H2O 7 60 90
6 Acetonitrile 5 60 30
7 EtOH 5 60 Trace


Subsequently, we agreeably found out that the presence of 5 mg of Cu(II)/L-His@Fe3O4, promoted the reaction efficiently and improved the yield to 91% (entry 4). The nature of solvent was then screened. In water, the reaction also proceeded smoothly and gave a good yield. In acetonitrile, however, only a low yield of (30%) was obtained (entry 6). When the reaction was carried out in, ethanol, almost no desired product was found (entries 7). Based on the above mentioned reasons, it was found that the water is the best solvent. The effect of temperature on reaction was examined. With increasing the temperature the yield of product also increases and it was found that optimal reaction temperature is 80 °C.

With the optimal reaction conditions in hand (Table 4, entry 4), the scope and generality of this protocol was investigated next. A wide variety of aromatic aldehydes and thiols were used for synthesis of 2-amino-3,5-dicarbonitrile-6-thio-pyridines. The results are summarized in Table 5. Meanwhile, the electronic properties and different positions of the substituents have no obvious effect on the reaction yields.

Table 5 Synthesis of 2-amino-3,5-dicarbonitrile-6-thio-pyridinesa
Entry Aldehyde Thiophenol Product Yieldb (%) Mp (°C) (ref.)
a Reaction conditions: arylaldehyde (1 mmol), thiol (1 mmol), malononitrile (2 mmol), catalyst (5 mg) and in water (5 mL) at 80 °C for 60 min.b Isolated yields.
1 image file: c6ra19776k-u63.tif image file: c6ra19776k-u64.tif image file: c6ra19776k-u65.tif 92 238–240 (ref. 29)
2 image file: c6ra19776k-u66.tif image file: c6ra19776k-u67.tif image file: c6ra19776k-u68.tif 90 220–222 (ref. 28)
3 image file: c6ra19776k-u69.tif image file: c6ra19776k-u70.tif image file: c6ra19776k-u71.tif 86 238–239 (ref. 25)
4 image file: c6ra19776k-u72.tif image file: c6ra19776k-u73.tif image file: c6ra19776k-u74.tif 91 233–235 (ref. 26)
5 image file: c6ra19776k-u75.tif image file: c6ra19776k-u76.tif image file: c6ra19776k-u77.tif 89 230–232 (ref. 26)
6 image file: c6ra19776k-u78.tif image file: c6ra19776k-u79.tif image file: c6ra19776k-u80.tif 95 217–218 (ref. 27)
7 image file: c6ra19776k-u81.tif image file: c6ra19776k-u82.tif image file: c6ra19776k-u83.tif 94 221–223 (ref. 27)
8 image file: c6ra19776k-u84.tif image file: c6ra19776k-u85.tif image file: c6ra19776k-u86.tif 87 245–250 (ref. 26)
9 image file: c6ra19776k-u87.tif image file: c6ra19776k-u88.tif image file: c6ra19776k-u89.tif 97 223–225 (ref. 27)
11 image file: c6ra19776k-u90.tif image file: c6ra19776k-u91.tif image file: c6ra19776k-u92.tif 94 315–317 (ref. 27)
11 image file: c6ra19776k-u93.tif image file: c6ra19776k-u94.tif image file: c6ra19776k-u95.tif 92 211–212 (ref. 27)
12 image file: c6ra19776k-u96.tif image file: c6ra19776k-u97.tif image file: c6ra19776k-u98.tif 89 225–227 (ref. 27)
13 image file: c6ra19776k-u99.tif image file: c6ra19776k-u100.tif image file: c6ra19776k-u101.tif 90 288–290 (ref. 27)
14 image file: c6ra19776k-u102.tif image file: c6ra19776k-u103.tif image file: c6ra19776k-u104.tif 93 240–242 (ref. 27)


Based on industrial green chemistry principles, the reusability of the catalyst is important for the large scale operation. Therefore, reusability of described catalyst was examined for the synthesis DHQ (Table 2, entry 1) and PHQ (Table 3, entry 1). After the first run, the catalyst was easily and rapidly separated from the reaction mixture using an external magnet and subsequently was used for the next run. As it can be seen from Fig. 7, the catalyst can be recycled at lease for six runs without any significant loss of its catalytic activity and efficient.


image file: c6ra19776k-f7.tif
Fig. 7 Recycling of Cu(II)/L-His@Fe3O4 for the model reaction under optimized conditions.

In summary, we have successfully developed an efficient and novel catalyst for several synthetic organic transformations. Cu(II)–L-histidine was grafted onto magnetic Fe3O4 nanoparticles, as a metal-chelating monomer via metal coordination interactions and histidine template. Copper(II) bound to L-histidine is in equilibrium with human serum albumin and may undergo mutual exchange which modulates the bioavailability of copper to the cell. A range of corresponding products were synthesized by this strategy with moderate to good yields under mild and green conditions in a heterogeneous system with short reaction times. These nanocatalysts have emerged as powerful tools for the efficient conversion of raw materials into useful chemicals of both industrial and pharmaceutical significance.

Furthermore, the Cu(II)/L-His@Fe3O4 nanocatalyst can be easily separated from the reaction mixture and the catalytic activity remained unchanged even after 6 successive recycling experiments.

Experimental

Materials

All the reagents and solvents were purchased from Sigma-Aldrich, Fluka or Merck and utilized without further purification.

The particle morphology was examined by measuring SEM using FESEM-TESCAN MIRA3. The products component measurement was carried out by the energy dispersive spectroscopy (EDS) using FESEM-TESCAN MIRA3 scanning electron microscopes. The thermogravimetric analysis (TGA) curves are recorded using a Shimadzu DTG-60 instrument. VSM measurements were performed using a Vibrating Sample Magnetometer (VSM) MDKFD. The magnetization measurements were carried out in an external field up to 15 kOe at several temperatures.

Nanostructures were characterized using a Holland Philips X'pert X-ray powder diffraction (XRD) diffractometer (Co Kα, radiation = 0.154056 nm). IR spectra were recorded as KBr pellets on a VRTEX 70 model BRUKER FTIR spectrophotometer. NMR spectra were recorded on a Bruker Avance III 400 MHz. Chemical shifts are given in ppm (δ) relative to internal TMS and coupling constants J are reported in Hz. Melting points were measured with an Electrothermal 9100 apparatus. The Cu amount of catalyst was measure by Inductively Coupled Plasma Atomic Emission Spectrometer (ICP-OES). The particle size and morphology were investigated by a Zeiss-EM10C transmission electron microscope (TEM) on an accelerating voltage of 80 kV.

Preparation of Cu(II)/L-His@Fe3O4 catalyst

Acryloyl chloride-coated magnetic nanoparticles (MNP-acryloxyl) were prepared according to the literature method.29 The resulting materials were dispersed in ethanol (10.0 mL), and then L-histidine (3.2 mmol) was added to it and stirred continuously for 1 week at room temperature. The L-His@Fe3O4 particles were separated by a magnetic field, washed with ethanol and dried under vacuum for 12 h.

The L-His@Fe3O4 (0.5 g), was added to the round-bottom flask containing a solution of copper(II) chloride (0.25 g) in ethanol (20 mL). The mixture was then stirred vigorously under reflux conditions for 8 h. The solid was separated by magnetic decantation. The magnetic catalyst was washed with copious amounts of ethanol and dried under vacuum at room temperature.

General synthesis for the preparation of 2,3-dihydroquinazolin-4(1H)-ones

A mixture of aldehyde (1 mmol), 2-aminobenzamide (1 mmol), Cu(II)/L-His@Fe3O4 (4 mg) and ethanol (4 mL) was stirred at 80 °C. Upon completion, the progress of the reaction was monitored by TLC. After the TLC indicates the disappearance of starting materials, the reaction was cooled to room temperature. The catalyst was separated by an external magnet and reused as such for the next experiment. The filtrate was evaporated to remove solvent, the resultant solid was then washed with ethanol to obtain pure 2,3-dihydroquinazolin-4(1H)-ones in 89–99% yields.
2-(4-Chlorophenyl)-2,3-dihydroquinazolin-4(1H)-one (Table 2, entry 1). White solid, mp 202–203 °C. 1H NMR (250 MHz, DMSO-d6): δ 8.29 (s, 1H), 7.61–7.41 (m, 5H), 7.26–7.2 (t, 1H), 6.75–6.63 (m, 2H), 7.12 (s, 1H), 6.75–6.63 (m, 2H), 5.75 (s, 1H) ppm. 13C NMR (62 MHz, DMSO-d6): δ 163.9, 148.1, 141.1, 133.8, 133.4, 129.2, 128.7, 127.8, 117.7, 115.4, 114.9, 66.2 ppm.
2-(4-Methylphenyl)-2,3-dihydroquinazolin-4(1H)-one (Table 2, entry 2). White solid, mp 225–226 °C. 1H NMR (250 MHz, DMSO-d6): δ 8.21 (s, 1H), 7.62–7.59 (d, 1H), 7.38–7.35 (d, 2H), 7.26–7.16 (m, 3H), 7.03 (s, 1H), 6.75–6.63 (m, 2H), 5.71 (s, 1H), 2.49–2.42 (s, 3H) ppm. 13C NMR (62 MHz, DMSO-d6): δ 164.1, 148.4, 139.1, 138.2, 133.7, 129.3, 127.8, 127.2, 117.5, 115.4, 114.9, 66.8, 21.2 ppm.
2-(4-Ethoxyphenyl)-2,3-dihydroquinazolin-4(1H)-one (Table 2, entry 7). White solid, mp 167–168 °C, 1H NMR (400 MHz, CDCl3): δ (ppm) 7.98 (brs, 1H), 7.6 (d, J = 6 Hz, 2H), 7.34 (s, 1H), 7.26 (d, J = 2 Hz, 1H), 6.87–7.03 (m, 3H), 6.65 (d, J = 5.6 Hz, 1H), 5.87 (s, 1H), 5.75 (s, 1H), 4.12 (t, J = 4 Hz, 2H), 1.45 (q, J = 6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 161.4, 148.9, 147.5, 131.52, 129.89, 120.7, 116.79, 116.01, 115.68, 69.82, 64.78, 15.9; IR (KBr): mmax 3300, 3060, 3000, 2930, 1666, 1650, 1610, 1487, 1387, 70.
2,2′-(1,2-Phenylene)bis(2,3-dihydroquinazolin-4(1H)-one) (Table 2, entry 11). White solid, mp 272–273 °C, 1H NMR (400 MHz, DMSO): δ (ppm) 7.87 (d, J = 8.4 Hz, 4H), 7.64 (s, 2H), 7.46 (s, 2H), 7.32 (d, J = 6 Hz, 2H), 7.15 (s, 2H), 6.69 (s, 3H), 6.63 (s, 2H), 5.75 (s, 2H). IR (KBr): mmax 3299, 3248, 3181, 2961, 2831, 1698, 1639, 1808, 1515, 1481, 1297, 1151, 742.
2-Isopropyl-2,3-dihydroquinazolin-4(1H)-one (Table 2, entry 17). White solid, mp 160–164 °C, 1H NMR (400 MHz, CDCl3): δ = 7.88 (d, J = 7.6 Hz, 1H), 7.31 (t, J = 7.2 Hz, 1H), 6.84 (t, J = 7.2 Hz, 1H), 6.74 (s, 1), 6.69 (d, J = 8 Hz, 1H), 4.72 (d, J = 4.4 Hz, 1H), 2.00 (m, 6H), 1.05 (d, J = 6.8 Hz, 6H). 13C NMR (100 MHz, CDCl3): δ = 165.52, 147.55, 133.87, 128.46, 118.97, 115.52, 114.51, 70.16, 32.82, 148.9, 16.94.

General method for the synthesis of polyhydroquinolines

4 mg of Cu(II)/L-His@Fe3O4 catalyst was ultrasonically dispersed in freshly distilled ethanol (5 mL). Then, a mixture of aldehydes (1 mmol), dimedone (1 mmol), ethyl acetoacetate (1 mmol) and ammonium acetate (1.2 mmol) was added. The resulting mixture was stirred at 50 °C for the appropriate time, as shown in Table 3. After completion of the reaction the catalyst was separated from the reaction mixture using an external magnet. Subsequently, the solvent was evaporated and the residue was purified by further recrystallisation in ethanol. A wide range of products were obtained in good to excellent yields (91–98%).
Ethyl 2,7,7-trimethyl-5-oxo-4-(p-tolyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Table 2, entry 3). White solid, mp 252–254 °C, 1H NMR (400 MHz, CDCl3) δ: 9.05 (s, 1H, NH), 7.01–7.29 (m, 4H), 5.03 (s, 1H), 4.04 (q, J = 8.2 Hz, 2H), 2.21 (m, 3H), 2.28 (s, 3H), 1.96 (s, 1H), 1.25 (t, J = 7.2 Hz, 3H), 1.11 (s, 3H), 0.98 (s, 3H) ppm. IR (KBr, cm−1): 3274, 2956, 1699, 1603, 1488, 1378, 1233, 1139, 1030, 748, 743.
Ethyl 4-(3,4-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Table 3, entry 5). White solid, mp 201–202 °C, IR (KBr, cm−1): 3203, 2958, 1692, 1601, 1485, 1378, 1216, 1139, 1029, 758, 730. 1H NMR (400 MHz, DMSO-d6) δ: 9.06 (s, NH), 6.74 (d, J = 16 Hz, 2H), 6.65 (d, J = 8 Hz, 1H), 4.80 (s, 1H), 4.02 (d, J = 8 Hz, 2H), 3.67 (s, 6H), 2.42 (d, J = 8 Hz, 1H), 2.28–2.32 (m, 4H), 2.21 (d, J = 16 Hz, 1H), 2.02 (d, J = 14 Hz, 1H), 1.17 (s, 3H), 1.03 (s, 3H), 0.90 (s, 3H) ppm. 13C NMR (100 MHz, DMSO-d6) δ: 194.8, 161.4, 149.9, 148.3, 147.4, 145.1, 144.9, 140.9, 119.6, 112.1, 111.9, 110.5, 104.3, 59.5, 55.8, 50.7, 35.6, 32.6, 29.7, 26.9, 18.7, 18.6, 14.7 ppm.
Ethyl 4-(4-ethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Table 2, entry 7). White solid, mp 176–178 °C, 1H NMR (400 MHz, CDCl3): δ = 7.19 (d, J = 6.4 Hz, 2H), 6.73 (d, J = 6.4 Hz, 2H), 5.80 (s, 1H), 4.99 (s, 1H), 4.06 (t, 2H), 3.96 (t, 2H), 2.15–2.38 (m, 7H), 1.37–1.38 (m, 3H), 1.20–1.21 (m, 3H), 1.07 (s, 3H), 0.95 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ = 198, 169, 158.3, 150.2, 144.7, 140.7, 130.1, 114.9, 113.1107.3, 64.3, 60.9, 51.9, 41.8, 36.8, 33.7, 30.6, 28.2, 20.3, 16.05, 15.4 ppm.
Ethyl 4-(3-hydroxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (Table 2, entry 11). White solid, mp 217–219 °C, IR (KBr, cm−1): 3274, 2950, 1690, 1600, 1497, 1377, 1214, 1144, 1033, 782, 722. 1H NMR (400 MHz, DMSO-d6) δ: 9.10 (s, OH), 9.04 (s, NH), 6.46–6.98 (m, 4H), 4.80 (s, 1H), 3.98 (q, J = 4 Hz, 2H), 2.44 (d, J = 16 Hz, 1H), 2.28 (q, J = 12 Hz, 3H), 2.17 (d, J = 16 Hz, 1H), 2.00 (d, J = 16 Hz, 1H), 1.61 (t, J = 7.2 Hz, 3H), 1.02 (s, 3H), 0.88 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 193.9, 166.0, 194.7, 167.4, 157.3, 149.9, 149.4, 145.2, 129.0, 118.6, 115.0, 113.0, 110.2, 104.1, 59.5, 55.7, 50.7, 36.0, 32.6, 29.6, 27.0, 18.06, 18.7, 14.6.

General method for synthesis of 2-amino-3,5-dicarbonitrile-6-thio-pyridines

To a stirred solution of aldehyde (1 mmol), malononitrile (2 mmol) and thiols (1 mmol) in water (4 mL), Cu(II)/L-His@Fe3O4 (5 mg) was added and the reaction mixture was stirred at 80 °C for 60 min. After reaction completion, the catalyst was separated by an external magnet and reused as such for the next experiment. The mixture was diluted with ethyl acetate and water solution and the extracted organic layer was dried over Na2SO4 (1.5 g) and the solvent was evaporated. The crude product was recrystallized from ethanol to obtain pure product.
2-Amino-4-(4-fluorophenyl)-6-(phenylthio)pyridine-3,5 dicarbonitrile (Table 5, entry 9). Yellow solid, mp 223–225 °C, 1H NMR (300 MHz, DMSO-d6) δ: 7.81 (d, J = 8.1 Hz, 2H), 7.60–7.59 (m, 2H), 7.55–7.51 (m, 5H), 5.51 (s, 2H).
2-Amino-4-(4-methoxy-phenyl)-6-phenylsulfanyl-pyridine-3,5-dicarbonitrile (Table 5, entry 14). Yellow solid, mp 240–242 °C, 1H NMR (300 MHz, CDCl3) δ: 7.43–7.59 (m, 7H), 7.08 (d, J = 8.8 Hz, 2H), 5.46 (s, 2H), 3.91 (3H, s).

Complete experimental procedures and relevant spectra (1H NMR and 13C NMR) for several prepared compounds, and the catalyst characterization data are available in the ESI.

Acknowledgements

Authors thank Ilam University for financial support of this research project.

References

  1. V. Feyer, O. Plekan, S. Ptasińska, M. Iakhnenko, N. Tsud and K. C. Prince, J. Phys. Chem. C, 2012, 116, 22960 CAS.
  2. D. J. Sullivan, I. Y. Gluzman and D. E. Goldberg, Science, 1996, 271, 219 CAS.
  3. A. L. Jones, M. D. Hulett and C. R. Parish, Immunol. Cell Biol., 2005, 83, 106 CrossRef CAS PubMed.
  4. G. N. Chen, X. P. Wu, J. P. Duan and H. Q. Chen, Talanta, 1999, 49, 319 CrossRef.
  5. Y. Hu, Q. Wang, C. Zheng, L. Wu, X. Hou and Y. Lv, Anal. Chem., 2014, 86, 842 CrossRef CAS PubMed.
  6. F. Carrera, E. S. Marcos, P. J. Merkling, J. Chaboy and A. Munoz-Paez, Inorg. Chem., 2004, 43, 6674 CrossRef CAS PubMed.
  7. S. J. Lippard and J. M. Berg, Principles of Bioinorganic Chemistry, University Science Books, Mill Valley, CA, USA, 1994 Search PubMed.
  8. P. Deschamps, P. P. Kilkarni, M. Gautam-Basak and B. Sarkar, Coord. Chem. Rev., 2005, 249, 895 CrossRef CAS.
  9. L. Gala, M. Lawson, K. Jomova, L. Zelenicky, A. Congradyova, M. Mazur and M. Valko, Molecules, 2014, 19, 980 CrossRef PubMed.
  10. Biochemistry of Copper, ed. B. Sarkar, T. P. A. Kruck, J. Peisach, P. Aisen and W. Blumberg, Academic Press, New York, 1966, p. 183 Search PubMed.
  11. B. Sarkar, Chem. Rev., 1999, 99, 2535 CrossRef CAS PubMed.
  12. B. Evertsson, Acta Crystallogr., 1969, 25, 30–41 CrossRef CAS.
  13. M. Kooti and M. Afshar, Mater. Res. Bull., 2012, 47, 3473 CrossRef CAS.
  14. M. Sheykhan, L. Ma'mani, A. Ebrahimi and A. Heydari, J. Mol. Catal. A: Chem., 2011, 335, 245 CrossRef.
  15. B. Panella, A. Vargas and A. Baiker, J. Catal., 2009, 261, 88 CrossRef CAS.
  16. S. Venkateswarlu, M. Satyanarayana, K. Srinivas and K. N. V. V. Aadisudhakar, Tetrahedron Lett., 2013, 54, 128 CrossRef CAS.
  17. M. Tajbakhsh, H. Alinezhad, M. Norouzi, S. Baghery and M. Akbari, J. Mol. Liq., 2013, 177, 44 CrossRef CAS.
  18. M. Abdollahi-Alibeik and A. Rezaeipoor-Anari, J. Magn. Magn. Mater., 2016, 398, 205 CrossRef CAS.
  19. M. Nasr-Esfahani, S. Jafar Hoseini, M. Montazerozohori, R. Mehrabi and H. Nasrabadi, J. Mol. Catal. A: Chem., 2014, 382, 99 CrossRef CAS.
  20. P. Murthy, D. Rambabu, G. R. Krishna, C. M. Reddy, K. R. S. Prasad, M. V. Basaveswara Rao and M. Pal, Tetrahedron Lett., 2012, 53, 863 CrossRef CAS.
  21. B. Vilas Labade, V. Pravin Shinde and S. Murlidhar Shingare, Tetrahedron Lett., 2013, 54, 5778 CrossRef.
  22. S. Kumar, P. Sharma, K. K. Kapoor and M. Singh Hundal, Tetrahedron, 2008, 64, 536 CrossRef CAS.
  23. B. V. Subba Reddy, A. Venkateswarlu, C. Madan and A. Vinu, Tetrahedron Lett., 2011, 52, 1891 CrossRef CAS.
  24. M. Thimmaiah, P. Li, S. Regati, B. Chen and J. Cong-Gui Zhao, Tetrahedron Lett., 2012, 53, 4870 CrossRef CAS PubMed.
  25. S. Ray and C. Mukhopadhyay, Letters in Applied NanoBioScience, 2014, 3, 220 Search PubMed.
  26. P. Manna and P. K. Maiti, Tetrahedron Lett., 2015, 56, 5094 CrossRef CAS.
  27. P. V. Shinde, S. S. Sonar, B. B. Shingate and M. S. Shingare, Tetrahedron Lett., 2010, 51, 1309 CrossRef CAS.
  28. J. Safaei-Ghomi, M. A. Ghasemzadeha and M. Mehrabib, Sci. Iran., Trans. C, 2013, 20, 549 CAS.
  29. A. Molla, S. Hussain and S. Affiliations, RSC Adv., 2014, 4, 29750 RSC.
  30. A. Ghorbani-Choghamarani and M. Norouzi, J. Mol. Catal. A: Chem., 2014, 395, 172–179 CrossRef CAS.
  31. A. Ghorbani-Choghamarani, Z. Darvishnejad and M. Norouzi, Appl. Organomet. Chem., 2015, 29, 707 CrossRef CAS.
  32. A. Ghorbani-Choghamarani and G. Azadi, RSC Adv., 2015, 5, 9752 RSC.
  33. M. Ghorbani-Choghamarani, M. Hajjami, M. Norouzi, Y. Abbasityula, V. Eigner and M. Dusek, Tetrahedron, 2013, 69, 6541 CrossRef.
  34. A. Ghorbani-Choghamarani and M. Norouzi, Lett. Org. Chem., 2013, 10, 562 CrossRef CAS.
  35. A. Ghorbani-Choghamarani and B. Tahmasbi, New J. Chem., 2016, 40, 1205 RSC.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c6ra19776k

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.